Cellular / Research

GHK-CU 100mg

COA Available Research Use Only Third Party Tested 99.48% COA Purity Lot HEL-6524116
$74.99
⇩ Download COA (PDF)

Product Information

SKUCU100
Strength100mg
CAS130120-57-9
Molecular Weight401.91 g/mol
FormulaC14H22CuN6O4
CategoryCellular / Research
Research UseResearch Use Only

Label / Documentation

Label PreviewView Label
COA (Batch)Download PDF
Third-Party TestedYes
Purity99.48%
LotHEL-6524116
MethodUPLC / MS
Research Use OnlyYes
♻ For laboratory research use only. Not for human or animal consumption.

Verify Amino Research product information and COA documentation through the Amino Research verification page at aminoresearch.net.

Product Overview

GHK-CU 100mg

GHK-Cu is a copper-binding tripeptide discussed in peer-reviewed literature reviewing laboratory, animal-model, fibroblast, and gene-expression research. The literature describes multiple experimental systems and proposed mechanisms rather than a single established clinical use.

This is preclinical and mechanistic research context. It does not establish safety, efficacy, an approved indication, or clinical suitability in humans or animals, and it is separate from this lot-specific quality record. This material is supplied only for laboratory research, with no dosing or administration guidance.

Research sources

Documentation and related records

Documentation status: Purity + Endotoxin COA.

Review the current GHK-CU 100mg documentation for lot HEL-6524116, the testing and COA guidance, and the Research Use Only compliance information. For adjacent catalog records, see GLOW 70mg, KLOW 80mg, KPV 10mg. These links support catalog navigation and do not imply equivalence or use.

Product Specifications

GHK-CU 100mg — Specifications

SKUCU100
Strength100mg
CAS Number130120-57-9
Molecular Weight401.91 g/mol
Molecular FormulaC14H22CuN6O4
Research CategoryCellular / Research
Purity99.48%
Testing StatusThird-Party Tested
COA LotHEL-6524116
Tested Content99.5 mg
Endotoxin< 0.05 EU/mL
Documentation StatusPurity + Endotoxin COA
COA StatusCOA Available
Research UseResearch Use Only
Testing & Documentation

Testing & documentation for GHK-CU 100mg

The current combined third-party report identifies GHK-CU 100mg for lot HEL-6524116 and reports separate results for tested content, purity, and endotoxin. Researchers should match the lot on the vial to the report and review the complete PDF; a COA documents the tested sample and does not establish clinical suitability.

Purity99.48%Third-party tested
Identity / ContentGHK-CU 100mg / 99.5 mgCurrent documentation
Analytical MethodUPLC / MSIdentity & purity
Labeled Content100mgPer research vial
Batch / LotHEL-6524116Match to vial label
Endotoxin< 0.05 EU/mLPurity + Endotoxin COA

Only documented test categories are shown. Where a value is not yet published it is shown as “Available on documentation” or “Pending.”

Research Use Notice

For laboratory research use only

GHK-CU 100mg is intended solely for laboratory research use by qualified research professionals. It is not for human or animal consumption and is not intended for diagnostic, therapeutic, or clinical use. No dosing or administration guidance is provided. Researchers are responsible for compliance with all applicable laws and regulations. Review Amino Research compliance and RUO information.

Quality & Supply Standards

How Amino Research materials are supplied

Purity + Endotoxin COA

Current documentation identifies lot HEL-6524116 for this GHK-CU 100mg record.

99.48% Purity

The current report lists this UPLC/MS purity result for the tested lot.

99.5 mg Tested Content

Tested content is reported separately from the labeled 100mg strength.

RUO Documentation

COA access and clear research-only limitations are linked from this product record.

Add to Cart

GHK-CU 100mg

Add this research-use material to your cart, or review its documentation. Pricing reflects current Amino Research pricing.

⇩ Download COA (PDF)
Product FAQ

GHK-CU 100mg — FAQ

What research context is available for GHK-Cu?

A peer-reviewed review summarizes laboratory, animal-model, fibroblast, and gene-expression studies involving GHK-Cu and discusses proposed mechanisms. That preclinical literature does not establish an approved human or animal use or catalog-lot equivalence.

What does the current GHK-CU 100mg COA document?

The current combined third-party report for lot HEL-6524116 reports 99.5 mg tested content, 99.48% purity by UPLC / MS, and < 0.05 EU/mL endotoxin. Review the complete lot-specific PDF.

How should researchers verify this documentation?

Match the product name and lot on the vial to the report, then review the method, purity, tested content, endotoxin result, and report date. See the testing and COA guidance and the COA Library.

Is GHK-CU 100mg intended for human or animal use?

No. It is supplied solely for laboratory research use by qualified research professionals. It is not for human or animal consumption and is not intended for diagnostic, therapeutic, or clinical use. No dosing or administration guidance is provided. Review the RUO and compliance information.

Which related Amino Research records can be reviewed?

Researchers can review GLOW 70mg, KLOW 80mg, KPV 10mg. These links are provided for catalog navigation, not as equivalence or use claims.

Documentation

Lab Documentation & Batch Records

Amino Research retains identity, purity, and endotoxin documentation organized by lot, and adds new records as additional batches are tested. The newest report is the current documentation; earlier reports are retained as batch history. Third-party tested. For laboratory research use only.

Current Documentation
Purity + Endotoxin
GHK-CU 100mgLot HEL-6524116 · Jun 29, 2026 · Horizon Analytical
View PDF
Documentation History / Batch Records
ProductLot / BatchTest TypeReceivedStatusReport
GHK-CU 100mgHEL-6524116Purity + EndotoxinJun 29, 2026CurrentView PDF
GHK-CU 100mgOn filePurityOn fileArchivedView PDF

Research Use Only. Documentation is provided for identity and quality verification for laboratory research use only. Not for human or animal consumption.